Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Andrews

Showing results (121-130 of 364) with videos related to

Pageof 37
Sort By:
European Journal of Medicinal Chemistry|August 28, 2022
Development of a PET radioligand for α2δ-1 subunit of calcium channels for imaging neuropathic painYu-Peng Zhou, Yang Sun, Kazue Takahashi, et al.
Infection and Immunity|December 23, 2003
Immune response to meningococcal serogroup C conjugate vaccine in asplenic individualsPaul Balmer, Michelle Falconer, Paula McDonald, et al.
The Pediatric Infectious Disease Journal|December 17, 2009
Immunogenicity of a reduced schedule of pneumococcal conjugate vaccine in healthy infants and correlates of protection for serotype 6B in the United KingdomDavid Goldblatt, Jo Southern, Lindsey Ashton, et al.
Open Forum Infectious Diseases|June 29, 2023
Epidemiological Impact of the Pediatric Live Attenuated Influenza Vaccine (LAIV) Program on Group A <i>Streptococcus</i> (GAS) Infection in EnglandMary A Sinnathamby, Fiona Warburton, Rebecca Guy, et al.
Bioinformatics (Oxford, England)|July 23, 2015
The application of a novel 'rising activity, multi-level mixed effects, indicator emphasis' (RAMMIE) method for syndromic surveillance in EnglandRoger A Morbey, Alex J Elliot, Andre Charlett, et al.
The Journal of Infection|August 9, 2025
The United Kingdom meningococcal vaccine (4CMenB) programme against gonorrhoea: A review of the evidence and knowledge gapsShamez N Ladhani, Sema Mandal, Hamish Mohammed, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2009
The immunogenicity of 7-valent pneumococcal conjugate vaccine versus 23-valent polysaccharide vaccine in adults aged 50-80 yearsDavid Goldblatt, Jo Southern, Nick Andrews, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 10, 2017
Live attenuated influenza vaccine effectiveness against hospitalisation due to laboratory-confirmed influenza in children two to six years of age in England in the 2015/16 seasonRichard Pebody, Bersabeh Sile, Fiona Warburton, et al.
Clinical and Vaccine Immunology : CVI|September 21, 2007
Comparison of phenotypically indistinguishable but geographically distinct Neisseria meningitidis Group B isolates in a serum bactericidal antibody assayJamie Findlow, Ann Holland, Nick Andrews, et al.
Journal of Virological Methods|September 19, 2009
Development of a focus reduction neutralization test (FRNT) for detection of mumps virus neutralizing antibodiesSunil R Vaidya, David W G Brown, Li Jin, et al.
Pageof 37

Showing results (121-130 of 364) with videos related to

Sort By:
Pageof 37
European Journal of Medicinal Chemistry|August 28, 2022
Development of a PET radioligand for α2δ-1 subunit of calcium channels for imaging neuropathic painYu-Peng Zhou, Yang Sun, Kazue Takahashi, et al.
Infection and Immunity|December 23, 2003
Immune response to meningococcal serogroup C conjugate vaccine in asplenic individualsPaul Balmer, Michelle Falconer, Paula McDonald, et al.
The Pediatric Infectious Disease Journal|December 17, 2009
Immunogenicity of a reduced schedule of pneumococcal conjugate vaccine in healthy infants and correlates of protection for serotype 6B in the United KingdomDavid Goldblatt, Jo Southern, Lindsey Ashton, et al.
Open Forum Infectious Diseases|June 29, 2023
Epidemiological Impact of the Pediatric Live Attenuated Influenza Vaccine (LAIV) Program on Group A <i>Streptococcus</i> (GAS) Infection in EnglandMary A Sinnathamby, Fiona Warburton, Rebecca Guy, et al.
Bioinformatics (Oxford, England)|July 23, 2015
The application of a novel 'rising activity, multi-level mixed effects, indicator emphasis' (RAMMIE) method for syndromic surveillance in EnglandRoger A Morbey, Alex J Elliot, Andre Charlett, et al.
The Journal of Infection|August 9, 2025
The United Kingdom meningococcal vaccine (4CMenB) programme against gonorrhoea: A review of the evidence and knowledge gapsShamez N Ladhani, Sema Mandal, Hamish Mohammed, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2009
The immunogenicity of 7-valent pneumococcal conjugate vaccine versus 23-valent polysaccharide vaccine in adults aged 50-80 yearsDavid Goldblatt, Jo Southern, Nick Andrews, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 10, 2017
Live attenuated influenza vaccine effectiveness against hospitalisation due to laboratory-confirmed influenza in children two to six years of age in England in the 2015/16 seasonRichard Pebody, Bersabeh Sile, Fiona Warburton, et al.
Clinical and Vaccine Immunology : CVI|September 21, 2007
Comparison of phenotypically indistinguishable but geographically distinct Neisseria meningitidis Group B isolates in a serum bactericidal antibody assayJamie Findlow, Ann Holland, Nick Andrews, et al.
Journal of Virological Methods|September 19, 2009
Development of a focus reduction neutralization test (FRNT) for detection of mumps virus neutralizing antibodiesSunil R Vaidya, David W G Brown, Li Jin, et al.
Pageof 37